Search - tctmd.com

Displaying 521 - 540 of 807

Sort: Relevancy | Date

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

High Baseline Fitness Level Tied to Improved Survival After MI

Michael O'Riordan

February 01, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

The Case for Reviving PCI Readmission Metrics: A Holistic Approach Could Improve Both Quality, Value

Yael L. Maxwell

January 27, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Daily News

Even a Little Exercise Yields Big Benefits, but Harm Unlikely at High Activity Levels

Michael O'Riordan

January 18, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Daily News

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Todd Neale

December 10, 2015

News Daily News

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Caitlin E. Cox

December 08, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Industry News

XENIOS® AG receives CE mark for its i-cor® Synchronized Cardiac Assist System

November 24, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Featured Fellow

Benjamin Z. Galper, MD, MPH

Yael L. Maxwell

November 15, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Shelley Wood

November 08, 2015

News Industry News

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

November 04, 2015

Advertisement

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

High Baseline Fitness Level Tied to Improved Survival After MI

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

The Case for Reviving PCI Readmission Metrics: A Holistic Approach Could Improve Both Quality, Value

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Even a Little Exercise Yields Big Benefits, but Harm Unlikely at High Activity Levels

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

XENIOS® AG receives CE mark for its i-cor® Synchronized Cardiac Assist System

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

Benjamin Z. Galper, MD, MPH

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content